AETHER Stock Overview
Aether Industries Limited manufactures and sells advanced intermediates and specialty chemicals in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Aether Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹845.50 |
| 52 Week High | ₹1,209.00 |
| 52 Week Low | ₹761.55 |
| Beta | 0 |
| 1 Month Change | 5.37% |
| 3 Month Change | -0.21% |
| 1 Year Change | -10.26% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.18% |
Recent News & Updates
Recent updates
Aether Industries Limited (NSE:AETHER) Not Lagging Industry On Growth Or Pricing
Mar 09
Here's Why We Think Aether Industries (NSE:AETHER) Is Well Worth Watching
Sep 29Results: Aether Industries Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 29If EPS Growth Is Important To You, Aether Industries (NSE:AETHER) Presents An Opportunity
Jun 09With Aether Industries Limited (NSE:AETHER) It Looks Like You'll Get What You Pay For
Apr 19Aether Industries' (NSE:AETHER) Profits Appear To Have Quality Issues
Nov 19Shareholder Returns
| AETHER | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.9% | -0.5% | 1.4% |
| 1Y | -10.3% | 55.3% | 46.1% |
Return vs Industry: AETHER underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: AETHER underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| AETHER volatility | |
|---|---|
| AETHER Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: AETHER has not had significant price volatility in the past 3 months.
Volatility Over Time: AETHER's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 889 | Ashwin Desai | www.aether.co.in |
Aether Industries Limited manufactures and sells advanced intermediates and specialty chemicals in India and internationally. It offers 4-(2-Methoxyethyl) phenol (4MEP), 3-Methoxy-2-Methylbenzoyl Chloride (MMBC) (2), thiophene-2-ethanol (T2E), N-Octyl-D-glucamine/1- deoxy-1-(Octylamino)-D-Glucitol (NODG), ortho tolyl benzo nitrile/4’- Methyl-2-cyanobiphynyl (OTBN), 1-2-(2Hydroxyethoxy) ethyl piperazine (HEEP), delta-valerolactone (DVL), and bifenthrin alcohol products. The company also provides contract research and manufacturing services.
Aether Industries Limited Fundamentals Summary
| AETHER fundamental statistics | |
|---|---|
| Market cap | ₹110.67b |
| Earnings (TTM) | ₹1.21b |
| Revenue (TTM) | ₹6.68b |
92.3x
P/E Ratio16.8x
P/S RatioIs AETHER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AETHER income statement (TTM) | |
|---|---|
| Revenue | ₹6.68b |
| Cost of Revenue | ₹3.34b |
| Gross Profit | ₹3.33b |
| Other Expenses | ₹2.12b |
| Earnings | ₹1.21b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.16 |
| Gross Margin | 49.92% |
| Net Profit Margin | 18.19% |
| Debt/Equity Ratio | 0.8% |
How did AETHER perform over the long term?
See historical performance and comparison